GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bio-Rad Laboratories Inc (NYSE:BIO.B) » Definitions » Net Margin %
中文

Bio-Rad Laboratories (Bio-Rad Laboratories) Net Margin % : 51.34% (As of Dec. 2023)


View and export this data going back to 1999. Start your Free Trial

What is Bio-Rad Laboratories Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Bio-Rad Laboratories's Net Income for the three months ended in Dec. 2023 was $350 Mil. Bio-Rad Laboratories's Revenue for the three months ended in Dec. 2023 was $681 Mil. Therefore, Bio-Rad Laboratories's net margin for the quarter that ended in Dec. 2023 was 51.34%.

The historical rank and industry rank for Bio-Rad Laboratories's Net Margin % or its related term are showing as below:

BIO.B' s Net Margin % Range Over the Past 10 Years
Min: -129.45   Med: 5.54   Max: 149.83
Current: -23.86


BIO.B's Net Margin % is ranked worse than
62.62% of 816 companies
in the Medical Devices & Instruments industry
Industry Median: 0.045 vs BIO.B: -23.86

Bio-Rad Laboratories Net Margin % Historical Data

The historical data trend for Bio-Rad Laboratories's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Rad Laboratories Net Margin % Chart

Bio-Rad Laboratories Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 76.08 149.83 145.57 -129.45 -23.86

Bio-Rad Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 113.34 10.19 -170.64 16.81 51.34

Competitive Comparison of Bio-Rad Laboratories's Net Margin %

For the Medical Devices subindustry, Bio-Rad Laboratories's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bio-Rad Laboratories's Net Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bio-Rad Laboratories's Net Margin % distribution charts can be found below:

* The bar in red indicates where Bio-Rad Laboratories's Net Margin % falls into.



Bio-Rad Laboratories Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Bio-Rad Laboratories's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-637.324/2671.262
=-23.86 %

Bio-Rad Laboratories's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=349.708/681.184
=51.34 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bio-Rad Laboratories  (NYSE:BIO.B) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Bio-Rad Laboratories Net Margin % Related Terms

Thank you for viewing the detailed overview of Bio-Rad Laboratories's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Bio-Rad Laboratories (Bio-Rad Laboratories) Business Description

Traded in Other Exchanges
Address
1000 Alfred Nobel Drive, Hercules, CA, USA, 94547
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas, Europe and Africa , and Asia-Pacific. Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.

Bio-Rad Laboratories (Bio-Rad Laboratories) Headlines